Vigil Neuroscience Inc Market Cap ($375.71 Million)
Market Cap & Net Worth: Vigil Neuroscience Inc (VIGL)
Vigil Neuroscience Inc market cap. Vigil Neuroscience Inc (NASDAQ:VIGL) has a market capitalization of $375.71 Million ($375.71 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13369 globally and #3264 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vigil Neuroscience Inc's stock price $8.05 by its total outstanding shares 46671500 (46.67 Million). Also see VIGL cash flow conversion for how efficiently the company converts equity into cash flow.
Vigil Neuroscience Inc Market Cap History (2022–2025)
Vigil Neuroscience Inc market cap history from 2022 to 2025. Data shows change from $583.39 Million to $375.71 Million (-11.87% CAGR). Check current stock price of Vigil Neuroscience Inc for real-time trading data and today's change.
Index Memberships
Vigil Neuroscience Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.01% | #361 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1315 of 3165 |
Weight: Vigil Neuroscience Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vigil Neuroscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vigil Neuroscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VIGL shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VIGL by Market Capitalization
Companies near Vigil Neuroscience Inc in the global market cap rankings as of November 5, 2026. Also see VIGL total asset value for a full breakdown of the balance sheet.
Key companies related to Vigil Neuroscience Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Vigil Neuroscience Inc (2022–2025)
Market capitalization of Vigil Neuroscience Inc from 2022 to today. Between 2022 and today, Vigil Neuroscience Inc's market cap moved from $583.39 Million to $ 375.71 Million, with a yearly change of -11.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $375.71 Million | +373.53% |
| 2024 | $79.34 Million | -49.70% |
| 2023 | $157.75 Million | -72.96% |
| 2022 | $583.39 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Vigil Neuroscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $375.71 Million USD |
| MoneyControl | $375.71 Million USD |
| MarketWatch | $375.71 Million USD |
| marketcap.company | $375.71 Million USD |
| Reuters | $375.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vigil Neuroscience Inc
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States. The company's lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells… Read more